![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Vienna.png)
March 27, 2019
Hilton Vienna Danube Waterfront
Vienna, Austria
ABOUT CHINA FOCUS@EUROPE VIENNA
Since the recent reform of China’s drug approval process, clinical trials and new drug approval in China has speeded up. In 2017 alone, 34 pharma products and 5 biotech products were approved, making a record high in the history. It opened the door for drug development companies around the world to the Chinese market and also ignited license-in interest from Chinese public pharma companies.
China Focus @ Europe Vienna is bringing together investors and pharma leaders from China and healthcare innovators for an exclusive event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations from around the world. The forum features premier 1-to-1 networking opportunities prior to and during the forum.
Mar 27, 2019 Hilton Vienna Danube Waterfront Vienna, Austria
ATTENDEE DEMOGRAPHICS
at Previous China Focus Events
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/04/1@2x.png)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/04/组-6@2x.png)
Attendees
European Countries
%
Executive Level Attendees
Chinese Companies and Investors
One-to-one meetings
Company Presentations
WHAT
TO
EXPECT
AGENDA
Plenary session: Grand Waterfront Hall 1
8:00 – 9:00 | Check-in |
9:00 – 9:10 | Opening Remarks |
9:10 – 9:40 | Keynote: Status and trends of Chinese investment in Europe Csaba Wolf – Business Development Director, Deloitte |
9:40 – 10:30 | PANEL 1: Opportunities and challenges with China-Europe partnership in life science and healthcare Andy Li – Founding Partner, BioSense Global LLC Dong Chen – Director and China head of business development, Jiangsu Hengrui Pharmaceutical Katherine Cohen – Venture Partner, Panacea Venture Olivier Reinhard – VP Head of business development transactions for China and Emerging Markets, Sanofi |
10:30 – 10:40 | Break |
10:40 – 11:10 | Cross-border Camp Talk: Strategic considerations for obtaining patents on your intellectual property assets Daniel J. Nevrivy – Founder, Nevrivy Patent Law Group P.L.L.C. |
11:10 – 12:00 | PANEL 2: European innovations meet China resources Aamir Shahzad – President, European Society for Translational Medicine Dianna Qian – Partner, Pivotal bioVenture Partners China Fei Tian – Principle, Vesalius Biocapital Gottfried Köhler – Chair of Advisory Board, European Society for Translational Medicine James Warr – Associate, Greenhill & Co. |
12:00 – 13:30 | Lunch |
13:30 – 14:20 | PANEL 3: Oversea strategies of Chinese innovative biotech & pharma Tom Du – Medical Partner, Shenzhen Share Capital Jun Bao – President and CEO, Impact Therapeutics Qingping Zeng – President and CEO, Fosun Orinove Ping Cao – VP business development, Henlius Biotech Sara Chen – Head of business development, Genfleet Therapeutics |
14:20 – 15:30 | Company Presentation |
15:30 – 15:40 | Break |
15:40 – 16:10 | Cross-border Camp Talk: Valuation of your licensing asset – deal or no deal Patrik Frei – CEO, Venture Valuation AG |
16:10- 17:00 | PANEL 4: Partnering opportunities with Chinese pharma Echo Hindle-Yang – CEO, MSQ Ventures Qun Dang – VP Global head of business development, Qilu Pharmaceutical John Xu – CEO and co-founder, Jemincare Therapeutics Carlos de Sousa – CEO, Immunicum AB |
18:00 – 20:00 | MyBioGate China Focus Dinner (Separate registration required) |
Download Sample Attendee List from past China Focus events
Download Program from past China Focus events
SPONSORS OF PREVIOUS CHINA FOCUS
![](https://events.mybiogate.com/europespring/wp-content/uploads/2018/12/McDermottLogo_2c_rgb-金牌赞助.jpg)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2018/12/Pharscin-Pharma-Logo.jpg)
MEDIA PARTNERS
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/01/HealthcareDrinks.jpg)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/01/BioPartner.jpg)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/vbc-logo-rgb-1.jpg)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/EUSTM-1.png)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/PASCO-1.jpeg)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/GoingPublic-Media-AG-1.png)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2018/12/StarTree-venture.jpg)
![](https://events.mybiogate.com/europespring/wp-content/uploads/2018/12/LSN-Banner-Logo.png)
INVITED SPEAKERS
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Csaba-Wolf.jpg)
Csaba Wolf
Business Development Director
Deloitte
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/Katherine-Cohen.jpg)
Katherine Cohen
Venture Partner
Panacea Venture
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/andy-li.jpg)
Andy Li
Founding Partner
Biosense Global LLC
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Olivier-Reihard新-1.jpg)
Olivier Reinhard
VP, BD&L for China and emerging markets
Sanofi
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Ping-Cao.jpg)
Ping Cao
VP business development
Henlius Biotech
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Dong-Chen新-1.jpg)
Dong Chen
Director and China head of business development
Jiangsu Hengrui Pharmaceutical
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/Jun-Bao.jpg)
Jun Bao
President and CEO
Impact Therapeutics
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/Dang-Qun.jpg)
Qun Dang
VP, Global head of business development
Qilu Pharmaceutical
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/Qingping-Zeng.jpg)
Qingping Zeng
President and CEO
Fosun Orinove
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Dianna-Qian.jpg)
Dianna Qian
Partner
Pivotal bioVenture Partners China
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/John-Xu.jpg)
John Xu
CEO and co-founder
Jemincare Therapeutics
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/02/Tom-Du.jpg)
Tom Du
Medical Partner
Shenzhen Share Capital
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Echo-Hindle-Yang.jpeg)
Echo Hindle-Yang
CEO & Founder
MSQ Ventures
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Fei-Tian.jpg)
Fei Tian
Principle
Vesalius Biocapital
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/Sara-Chen-1.jpg)
Sara Chen
Head of business development
Genfleet Therapeutics
![](https://events.mybiogate.com/europespring/wp-content/uploads/2019/03/James-Warr.jpg)
James Warr
Associate
Greenhill & Co.
Youwen (Allen) Dai
Registratin, Sponsorship and Collaboration (U.S. and Europe)
Xinxin Li
Registration, Group Delegation and Presenting Companies (U.S.)
Han Yan
Hilton Vienna Danube Waterfront
Address:
Handelskai 269, 1020 VIENNA, Austria
TEL: +43-1-72777
FAX: +43-1-72777